Amgen's MariTide phase 2 trial - 20% weight loss, no plateau, once a month injection

Status
Not open for further replies.
Apparently the market thinks 20% is weak sauce, shares getting killed
 
clayd said:
Apparently the market thinks 20% is weak sauce, shares getting killed
20% is quite good. While it's about the same as for tirzepatide, if they offer it for 10-50% less than Zepbound and offer once per month dosing, there is a lot of money to be made. With that said, while I invest in the stock market, I never pick winners and only invest in S & P 500 index funds or bonds; I never try to pick winners. I follow the advice of Jack Bogle: If you want to find a needle in a haystack, buy the haystack.
 
penewbie said:
They had some pretty alarming bone loss news recently, I wouldn't get too excited.
One won't have to lose fat or muscle in order to lose weight. Maybe keeping the fat will enable the drug to avoid causing the GLP-1 chills from which I now suffer. Bones are overrated: Many invertebrates manage to do just fine without them.
 
keangkong said:
One won't have to lose fat or muscle in order to lose weight. Maybe keeping the fat will enable the drug to avoid causing the GLP-1 chills from which I now suffer. Bones are overrated: Many invertebrates manage to do just fine without them.
Have u tried to be on test C or E while on your weight loss journey with GLP1s?
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,620
Messages
55,146
Members
1
Latest member
Admin
Back
Top